Ex-Wells Fargo exec fined $17M for role in fake accounts scandal
By 
Aaron Nicodemus2023-03-16T15:36:00
The former head of Wells Fargo’s community bank will pay a $17 million fine issued by the Office of the Comptroller of the Currency (OCC) for her role in the bank’s fake accounts scandal.
The OCC’s order found Carrie Tolstedt “was significantly responsible for the systemic sales practices misconduct at the bank” and that the bank’s business model “imposed unreasonable sales goals on its employees, along with unreasonable pressure to meet such goals.”
Tolstedt agreed to pay the fine Jan. 19, but OCC Senior Deputy Comptroller Gregory Coleman didn’t sign off on the order until March 9. The OCC published the order in a press release Wednesday.
Related articles
-
News BriefEx-Wells Fargo exec dodges prison for fake accounts role
Carrie Tolstedt, the former head of Wells Fargo’s community bank who pleaded guilty to obstructing justice regarding her role in the bank’s infamous fake accounts scandal, will not serve prison time.
-
News BriefEx-Wells Fargo exec to pay $5M in SEC settlement over fake accounts
Carrie Tolstedt, the former head of Wells Fargo’s community bank, agreed to pay nearly $5 million to settle charges levied by the Securities and Exchange Commission related to the bank’s fake account scandal.
-
News BriefWells Fargo to pay $1B to settle suit over consent order noncompliance
Wells Fargo agreed to pay $1 billion to settle a class-action lawsuit filed by shareholders who claimed the bank overstated its progress in complying with regulatory orders related to its 2016 fake accounts scandal.
More from Regulatory Enforcement
-
News BriefCFPB ends probe into Meta’s financial advertising practices
Meta says it is no longer under investigation by the U.S. Consumer Financial Protection Bureau (CFPB), the latest instance of the agency scaling back enforcement under President Donald Trump.
-
News BriefTexas sues Johnson & Johnson, Kenvue over alleged misleading marketing of Tylenol
Texas Attorney General Ken Paxton sued two pharmaceutical companies for ”deceptively marketing Tylenol to pregnant mothers” despite risks linked to autism. The filing came two days before HHS Secretary Robert F. Kennedy Jr. appeared to walk back the claims.
-
News BriefCFPB scraps bad-actor registry, citing cost-benefit issues
The Consumer Financial Protection Bureau shut down a registry of non-bank financial firms that broke consumer laws. The agency cites the costs being ”not justified by the speculative and unquantified benefits to consumers.”